当前位置: X-MOL 学术FEBS J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
One ring closer to a closure: the crystal structure of the ES3 hydroxymethylbilane synthase intermediate
The FEBS Journal ( IF 5.5 ) Pub Date : 2023-10-20 , DOI: 10.1111/febs.16982
Helene J. Bustad 1 , Marthe S. Christie 1 , Mikko Laitaoja 2 , Aasne K. Aarsand 1, 3 , Aurora Martinez 4 , Janne Jänis 2 , Juha P. Kallio 4
Affiliation  

Hydroxymethylbilane synthase (HMBS), involved in haem biosynthesis, catalyses the head-to-tail coupling of four porphobilinogens (PBGs) via a dipyrromethane (DPM) cofactor. DPM is composed of two PBGs, and a hexapyrrole is built before the tetrapyrrolic 1-hydroxymethylbilane product is released. During this elongation, stable enzyme (E) intermediates are formed from the holoenzyme, with additional PBG substrates (S): ES, ES2, ES3 and ES4. Native PAGE and mass spectrometry of the acute intermittent porphyria (AIP)-associated HMBS variant p.Arg167Gln demonstrated an increased amount of ES3. Kinetic parameters indicated catalytic dysfunction, however, the product release was not entirely prevented. Isolation and crystal structure analysis of the ES3 intermediate (PDB: 8PND) showed that a pentapyrrole was fully retained within the active site, revealing that polypyrrole elongation proceeds within the active site via a third interaction site, intermediate pyrrole site 3 (IPS3). The AIP-associated HMBS variant p.Arg195Cys, located on the opposite side to p.Arg167Gln in the active site, accumulated the ES4 intermediate in the presence of excess PBG, implying that product hydrolysis was obstructed. Arg167 is thus involved in all elongation steps and is a determinant for the rate of enzyme catalysis, whereas Arg195 is important for releasing the product. Moreover, by substituting residues in the vicinity of IPS3, our results indicate that a fully retained hexapyrrole could be hydrolysed in a novel site in proximity of the IPS3.

中文翻译:

一个接近闭合的环:ES3 羟甲基双烷合酶中间体的晶体结构

羟甲基胆烷合酶 (HMBS) 参与血红素生物合成,通过二吡咯甲烷 (DPM) 辅因子催化四种胆色素原 (PBG) 的头尾偶联。 DPM由两个PBG组成,在四吡咯1-羟甲基联烷产物释放之前先构建了一个六吡咯。在此延伸过程中,由全酶形成稳定的酶 (E) 中间体,并具有额外的 PBG 底物 (S):ES、ES 2、ES 3和 ES 4。急性间歇性卟啉症 (AIP) 相关的 HMBS 变体 p.Arg167Gln 的非变性 PAGE 和质谱分析表明 ES 3的量增加。动力学参数表明催化功能障碍,然而,产物释放并未完全被阻止。 ES 3中间体 (PDB: 8PND) 的分离和晶体结构分析表明,五吡咯完全保留在活性位点内,表明聚吡咯在活性位点内通过第三个相互作用位点(中间体吡咯位点 3 (IPS3))进行延伸。 AIP 相关的 HMBS 变体 p.Arg195Cys 位于活性位点 p.Arg167Gln 的相对侧,在过量 PBG 存在的情况下积累 ES 4中间体,这意味着产物水解受到阻碍。因此,Arg167 参与所有延伸步骤,并且是酶催化速率的决定因素,而 Arg195 对于释放产物很重要。此外,通过取代 IPS3 附近的残基,我们的结果表明完全保留的六吡咯可以在 IPS3 附近的新位点水解。
更新日期:2023-10-20
down
wechat
bug